Epithelial-mesenchymal transition: a new target in anticancer drug discovery

Fabrizio Marcucci, Giorgio Stassi, Ruggero De Maria Marchiano

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

199 Citazioni (Scopus)


The conversion of cells with an epithelial phenotype into cells with a mesenchymal phenotype, referred to as epithelial-mesenchymal transition, is a critical process for embryonic development that also occurs in adult life, particularly during tumour progression. Tumour cells undergoing epithelial-mesenchymal transition acquire the capacity to disarm the body's antitumour defences, resist apoptosis and anticancer drugs, disseminate throughout the organism, and act as a reservoir that replenishes and expands the tumour cell population. Epithelial-mesenchymal transition is therefore becoming a target of prime interest for anticancer therapy. Here, we discuss the screening and classification of compounds that affect epithelial-mesenchymal transition, highlight some compounds of particular interest, and address issues related to their clinical application.
Lingua originaleEnglish
pagine (da-a)311-325
Numero di pagine15
RivistaNature Reviews Drug Discovery
Stato di pubblicazionePubblicato - 2016


  • cancer


Entra nei temi di ricerca di 'Epithelial-mesenchymal transition: a new target in anticancer drug discovery'. Insieme formano una fingerprint unica.

Cita questo